Research & Publications †
( † Disclaimer: This search is powered by PubMed, a service of the U.S. National Library of Medicine. PubMed is a third-party website with no affiliation with Cleveland Clinic.)
Biographical Sketch
Hossam Elzawawy, MD, MS is a board-certified rheumatologist at the Cleveland Clinic in Florida and Assistant Professor of Medicine at Charles E. Schmidt College of Medicine, Florida Atlantic University who specializes in the treatment of rheumatoid arthritis, psoriatic arthritis, lupus, gout, vasculitis, ankylosing spondylitis, polymyositis and scleroderma.
He received his medical degree at Ain Shams University School of Medicine, Cairo, Egypt in 1995 and trained in Orthopaedics from 1997 to 2000. He was appointed as an Assistant Lecturer of Orthopaedics at Ain Shams University. In 2000, he received a Master's Degree in Orthopaedics.
From 2001 to 2004, Dr. Elzawawy was a Post-Doctoral Research Fellow at Washington University School of Medicine in St. Louis, MO. Dr. Elzawawy's research focused on bone fracture and ligament healing.
From 2004-2007, Dr. Elzawawy completed Internal Medicine residency at St. Vincent's Medical Center a major affiliate of the University of Connecticut. In 2007, he joined the Cleveland Clinic in Cleveland, OH and completed Rheumatology fellowship in 2009. During his fellowship Dr. Elzawawy investigated hyaluronate as a marker of inflammation in patients with rheumatoid arthritis.
Dr. Elzawawy is an active member of the American College of Rheumatology. He had numerous presentations to nationally recognized organizations including the American College of Rheumatology and the Orthopaedic Research Society. He has publications in the Journal of Orthopaedic Research, Journal of Biomechanics, Arthritis Advisor and the Cleveland Clinic Journal of Medicine. He is certified by the American Board of Internal Medicine with a sub-specialty in Rheumatology
Specialty Interests
Arthritis, bursitis, gout, infusion therapy, joint aspiration, joint injections
Industry Relationships
Cleveland Clinic physicians and scientists report if they
have any collaborations with the pharmaceutical or medical
device industries as part of the Cleveland Clinic’s
procedures. The Cleveland Clinic publicly discloses
payments to its physicians and scientists for speaking and
consulting of $5,000 or more per year, and any equity,
royalties, and fiduciary relationships in companies with
which they collaborate. In publicly disclosing this
information, the Cleveland Clinic tries to provide
information as accurately as possible about its doctors’
connections with industry and those of their immediate
family members. As of 9/22/2010,
Dr. Elzawawy has reported no financial relationship with
industry that is applicable to this listing. Patients
should feel free to contact their doctor about
relationships with industry and how the relationships are
overseen by the Cleveland Clinic. To learn more about
the Cleveland Clinic’s policies on collaborations with
industry and innovation management, go to our
Integrity in Innovation page.
